This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

ELYM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $49,952,816.64

Insider Selling (Last 12 Months): $2,146,236.31

Eliem Therapeutics Insider Trading History Chart

Eliem Therapeutics Share Price & Price History

^$3.25

▲ +0.19 (6.21%)

As of 11/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Breaking News: Tesla headed to $500…

From WealthPress | Ad

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Eliem Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2024	Emily Pimblett	CAO	Sell	1,191	$8.18	$9,742.38	7,564
7/22/2024	Valerie Morisset	EVP	Sell	69,005	$8.03	$554,110.15	31,317
7/19/2024	Valerie Morisset	EVP	Sell	60,201	$7.21	$434,049.21	100,322
7/17/2024	Valerie Morisset	EVP	Sell	3,207	$6.91	$22,160.37	199,099
7/15/2024	Valerie Morisset	EVP	Sell	42,377	$7.01	$297,062.77	252,306
7/11/2024	Valerie Morisset	EVP	Sell	50,000	$7.11	$355,500.00	344,683
7/9/2024	Valerie Morisset	EVP	Sell	5,931	$6.66	$39,500.46	444,683
7/5/2024	Valerie Morisset	EVP	Sell	12,342	$7.06	$87,134.52	450,614
7/3/2024	Valerie Morisset	EVP	Sell	50,000	$6.76	$338,000.00	462,956
6/27/2024	Ra Capital Management, L.P.	Director	Buy	13,008,546	$3.84	$49,952,816.64	23,521,757
6/20/2024	Emily Pimblett	CAO	Sell	1,245	$7.21	$8,976.45	3,755

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

SEC Filings (Institutional Ownership Changes) for Eliem Therapeutics (NASDAQ:ELYM)

69.76% of Eliem Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Eliem Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	38,859	$0.20M	0.0%	+1,428.1%	0.131%
11/15/2024	Barclays PLC	38,859	$0.20M	0.0%	+1,428.1%	0.131%
11/15/2024	Jane Street Group LLC	10,907	$56K	0.0%	N/A	0.037%
11/15/2024	Sphera Funds Management LTD.	181,970	$0.93M	0.1%	-15.4%	0.612%
11/15/2024	State Street Corp	315,036	$1.60M	0.0%	+433.9%	1.059%
11/15/2024	Samsara BioCapital LLC	2,609,114	$13.28M	2.6%	-20.0%	8.770%
11/15/2024	Point72 Asset Management L.P.	590,946	$3.01M	0.0%	N/A	1.986%
11/15/2024	Parkman Healthcare Partners LLC	278,775	$1.42M	0.2%	N/A	0.937%
11/15/2024	Ikarian Capital LLC	175,100	$0.89M	0.1%	+75.1%	0.589%
11/15/2024	Janus Henderson Group PLC	3,606,495	$18.30M	0.0%	+10.8%	12.122%
11/14/2024	Ally Bridge Group NY LLC	1,229,292	$6.26M	3.3%	+145.9%	4.132%
11/14/2024	MetLife Investment Management LLC	17,769	$90K	0.0%	N/A	0.060%
11/13/2024	Great Point Partners LLC	248,168	$1.26M	0.4%	N/A	0.834%
11/13/2024	Advantage Alpha Capital Partners LP	48,169	$0.25M	0.1%	N/A	0.162%
11/13/2024	The Manufacturers Life Insurance Company	49,524	$0.25M	0.0%	N/A	0.166%
11/12/2024	Valence8 US LP	12,045	$61K	0.0%	N/A	0.040%
11/12/2024	Charles Schwab Investment Management Inc.	70,093	$0.36M	0.0%	+309.2%	0.236%
11/8/2024	Segall Bryant & Hamill LLC	58,411	$0.30M	0.0%	N/A	0.196%
10/29/2024	Chicago Partners Investment Group LLC	16,966	$81K	0.0%	N/A	0.057%
10/3/2024	SG Americas Securities LLC	11,715	$60K	0.0%	N/A	0.039%
8/16/2024	Driehaus Capital Management LLC	696,057	$4.95M	0.0%	-14.2%	2.340%
8/15/2024	Affinity Asset Advisors LLC	1,670,661	$11.88M	1.4%	N/A	5.615%
8/14/2024	Ally Bridge Group NY LLC	500,000	$3.56M	2.1%	N/A	1.681%
8/9/2024	Renaissance Technologies LLC	37,000	$0.26M	0.0%	+248.5%	0.124%
8/9/2024	Dimensional Fund Advisors LP	12,560	$89K	0.0%	N/A	0.042%
8/1/2024	Rhumbline Advisers	8,233	$59K	0.0%	N/A	0.028%
7/26/2024	Bank of New York Mellon Corp	18,845	$0.13M	0.0%	N/A	0.063%
4/23/2024	BML Capital Management LLC	2,193,742	$6.01M	4.0%	+0.6%	7.914%
1/30/2024	BML Capital Management LLC	2,180,000	$5.89M	4.4%	+12.5%	7.907%
1/26/2024	Cerity Partners LLC	13,821	$37K	0.0%	N/A	0.050%
11/13/2023	Silverarc Capital Management LLC	121,110	$0.32M	0.1%	-75.5%	0.447%
10/23/2023	BML Capital Management LLC	1,938,263	$5.10M	4.7%	+22.4%	7.155%
8/15/2023	Silverarc Capital Management LLC	494,089	$1.38M	0.4%	+1.7%	1.830%
8/14/2023	Driehaus Capital Management LLC	810,593	$2.27M	0.0%	+20.3%	3.003%
7/24/2023	BML Capital Management LLC	1,583,170	$4.43M	4.0%	-4.5%	5.866%
4/14/2023	BML Capital Management LLC	1,658,170	$4.81M	4.2%	-9.1%	6.148%
2/14/2023	Driehaus Capital Management LLC	551,942	$2.03M	0.0%	+58.3%	2.077%
2/13/2023	BML Capital Management LLC	1,825,134	$6.70M	6.4%	N/A	6.869%
2/1/2023	Bank of Montreal Can	25,244	$93K	0.0%	N/A	0.095%
11/8/2022	Atom Investors LP	67,074	$0.22M	0.1%	+154.9%	0.252%
10/28/2022	Silverarc Capital Management LLC	402,088	$1.30M	0.4%	-43.6%	1.513%
8/16/2022	Parkwood LLC	67,202	$67K	0.2%	+63.4%	0.253%
7/25/2022	Silverarc Capital Management LLC	713,009	$2.15M	0.7%	+707.7%	2.684%
5/12/2022	Monashee Investment Management LLC	227,201	$1.91M	0.6%	-24.3%	0.855%
5/9/2022	Qube Research & Technologies Ltd	15,874	$0.13M	0.0%	N/A	0.060%
2/19/2022	Woodline Partners LP	373,368	$3.91M	0.1%	-3.6%	1.406%
2/15/2022	Samlyn Capital LLC	1,703,546	$17.82M	0.2%	+1.3%	6.417%
2/11/2022	Parkwood LLC	30,609	$0.32M	0.1%	N/A	0.115%
2/7/2022	Monashee Investment Management LLC	300,000	$3.14M	0.8%	-1.7%	1.130%
2/2/2022	New York State Common Retirement Fund	3,359	$35K	0.0%	N/A	0.013%
1/28/2022	Allspring Global Investments Holdings LLC	2,880	$30K	0.0%	N/A	0.011%
12/29/2021	Hudson Bay Capital Management LP	100,000	$1.80M	0.0%	N/A	0.377%
11/15/2021	Tudor Investment Corp Et Al	287,294	$5.17M	0.0%	N/A	1.082%
11/15/2021	RA Capital Management L.P.	13,150,849	$236.45M	3.3%	N/A	49.536%
11/15/2021	Caas Capital Management LP	75,000	$1.35M	0.0%	N/A	0.283%
11/12/2021	Geode Capital Management LLC	76,904	$1.38M	0.0%	N/A	0.290%
11/10/2021	Goldman Sachs Group Inc.	165,952	$2.98M	0.0%	N/A	0.625%
11/9/2021	BlackRock Inc.	332,126	$5.97M	0.0%	N/A	1.251%
11/9/2021	Monashee Investment Management LLC	305,233	$5.49M	1.0%	N/A	1.150%
11/4/2021	Deutsche Bank AG	4,063	$73K	0.0%	N/A	0.015%

Data available starting January 2016

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $3.25

$3.03

$3.34

50 Day Range

MA: $5.10

$3.06

$8.46

52 Week Range

Now: $3.25

$2.35

$11.55

Volume

303,805 shs

Average Volume

486,688 shs

Market Capitalization

$96.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Eliem Therapeutics?: Eliem Therapeutics' top insider shareholders include:
Ra Capital Management, LP (Director)
Valerie Morisset (EVP)
Emily Pimblett (CAO)
Learn More about top insider investors at Eliem Therapeutics.
Who are the major institutional investors of Eliem Therapeutics?: Eliem Therapeutics' top institutional shareholders include:
Janus Henderson Group PLC — 12.12%
Samsara BioCapital LLC — 8.77%
Ally Bridge Group NY LLC — 4.13%
Point72 Asset Management L.P. — 1.99%
State Street Corp — 1.06%
Parkman Healthcare Partners LLC — 0.94%
Learn More about top institutional investors of Eliem Therapeutics stock.
Which institutional investors are selling Eliem Therapeutics stock?: During the last quarter, ELYM stock was sold by these institutional investors:
Samsara BioCapital LLC
Sphera Funds Management LTD.
In the last year, company insiders that have sold Eliem Therapeutics company stock include:
Ra Capital Management, LP (Director)
Valerie Morisset (EVP)
Learn More investors selling Eliem Therapeutics stock.
Which institutional investors are buying Eliem Therapeutics stock?: In the last quarter, ELYM stock was purchased by institutional investors including:
Ally Bridge Group NY LLC
Point72 Asset Management L.P.
Janus Henderson Group PLC
Parkman Healthcare Partners LLC
State Street Corp
Great Point Partners LLC
Ikarian Capital LLC
Segall Bryant & Hamill LLC